Amazon could face a significant impact from Donald Trump's new tariffs on Chinese imports.Morgan Stanley estimates Amazon to be the most-exposed among e-commerce companies the bank covers.A large chunk of Amazon's third-party sellers are also China-based.Amazon could be one of the hardest-hit e-commerce retailers by new tariffs on imports from China. Morgan Stanley wrote in a note on Monday that roughly 25% of the cost of products directly sold by Amazon come from China, exposing them to the new tariffs. Th ...

文章核心观点 Levi & Korsinsky律所通知Integral Ad Science Holding Corp.投资者有关证券集体诉讼事宜，指控公司在特定时期存在证券欺诈，投资者可在规定时间申请成为首席原告，律所经验丰富 [1] 案件详情 - 被告被指控作出虚假陈述或隐瞒情况，包括IAS面临新的竞争定价压力趋势，被迫降价以应对需求疲软和收入增长放缓 [2] - IAS定价功能不再“有利”，无法维持定价和推动价格上涨 [2] - 定价成为IAS与竞争对手达成重大续约和新交易的关键差异化因素 [2] - 竞争导致的定价压力风险已实际发生 [2] - IAS公开声明在相关时间内存在重大虚假和误导性 [2] 后续安排 - 若在相关时间段内遭受损失，投资者需在2025年3月31日前申请成为首席原告，不担任首席原告也可参与赔偿分配 [3] - 作为集体成员，投资者无需支付任何自付费用或费用即可获得赔偿，参与无成本和义务 [3] 律所优势 - 过去20年，Levi & Korsinsky团队为受害股东争取数亿美元赔偿，在复杂证券诉讼中经验丰富 [4] - 律所拥有超70名员工服务客户，连续七年跻身ISS证券集体诉讼服务公司美国前50强报告 [4] 联系方式 - 律所名称为Levi & Korsinsky, LLP，联系人有Joseph E. Levi, Esq.和Ed Korsinsky, Esq. [5] - 地址为纽约市白厅街33号17楼，邮编10004 [5] - 邮箱为jlevi@levikorsinsky.com，电话为(212) 363 - 7500，传真为(212) 363 - 7171，网址为www.zlk.com [5]

NEW YORK, Feb. 04, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Novo Nordisk A/S (NYSE: NVO) between November 2, 2022 and December 19, 2024, both dates inclusive (the “Class Period”), of the important March 25, 2025 lead plaintiff deadline. SO WHAT: If you purchased Novo Nordisk securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement ...

FILE PHOTO: Robert F. Kennedy Jr., U.S. President Trump's nominee to be secretary of Health and Human Services, testifies before a Senate Health, Education, Labor, and Pensions (HELP) Committee confirmation hearing on Capitol Hill in Washington, U.S., January 30, 2025.Shares of vaccine companies fell on Tuesday after a Senate panel voted to advance Robert F. Kennedy Jr.'s nomination to lead the Department of Health and Human Services to the full chamber. The committee voted 14 to 13 to advance Kennedy in a ...

Leading buy now, pay later (BNPL) solution provider Affirm Holdings, Inc. (AFRM) is set to report its second-quarter fiscal 2025 results on Feb. 6, 2025, after the closing bell. The Zacks Consensus Estimate for the to-be-reported quarter’s bottom line is currently pegged at a loss of 21 cents per shareon revenues of $803.48 million.See the Zacks Earnings Calendar to stay ahead of market-making news.The fiscal second-quarter earnings estimate has deteriorated over the past month. The bottom-line projection i ...

Susvimo is the first and only continuous delivery treatment that offers an alternative to regular eye injections to treat diabetic macular edema (DME)With as few as two treatments per year, Susvimo may help people with DME maintain their visionApproval marks the second indication for Susvimo in addition to neovascular or ‘wet’ age-related macular degeneration (nAMD) Basel, 04 February 2025 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that the US Food and Drug Administration (FDA) has approved Susvim ...

Arguably one of the most prominent and striking images to come out of last Monday’s second presidential inauguration of Donald Trump, which took place inside the U.S. Capitol Rotunda in Washington, D.C., was that of three front row attendees: Elon Musk, Jeff Bezos, and Mark Zuckerberg -- the newly minted "broligarchs." All three Big Tech billionaires have been far from shy with their support -- though some more reluctant than others -- for the MAGA leader. With promises of tax cuts and free reign for ventur ...

About this content About Oliver Haill Oliver has been writing about companies and markets since the early 2000s, cutting his teeth as a financial journalist at Growth Company Investor with a focusing on AIM companies and small caps, before a few years later becoming a section editor and then head of research. He joined Proactive after a couple of years freelancing, where he worked for the Financial Times Group, ITV, Press Association, Reuters sports desk, the London Olympic News Service, Rugby World Cup ...

I assigned a “Buy” rating to Palantir Technologies Inc. (NASDAQ: PLTR ) in November 2024, discussing their accelerated demands for their AIP technology, across both commercial and government markets. Since then, the stock price has surged by more than 75%. PalantirAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. ...

Space company Rocket Lab USA (RKLB 4.09%) enjoyed a modest stock price bump in early trading on the Nasdaq Tuesday, rising 3.7% through 10 a.m. ET. The curious thing is that this bump came after what initially appears to be bad news.Last night Rocket Lab announced it will delay its next Electron rocket launch.Does Rocket Lab have a problem?Rocket Lab had an Electron all ready to launch a handful of Internet of Things (IoT) satellites into orbit for customer Kineis today. The company had to postpone launch t ...